netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

The National Eye Institute Turns 50

Research to Prevent Blindness congratulates the National Eye Institute (NEI) on its 50 year anniversary in 2018! This exciting milestone marks five decades of diagnosing and treating eye disease and vision impairment since NEI was established in 1968.

In remarks given at the National Eye Institute’s 50th Anniversary Capitol Hill Reception on March 21, 2018, in Washington, DC, sponsored by Congressman Pete Sessions of Texas, RPB President Brian F. Hofland, PhD, recounted how RPB and the NEI have always been connected.

RPB President Brian F. Hofland, PhD, addresses the audience at the NEI's 50th Anniversary Capitol Hill Reception on March 21, 2018. 

“When RPB was created in 1960, its founder, Jules Stein, a successful businessman who was an ophthalmologist by training, and RPB’s President, David Weeks, both felt passionately that the federal government needed to focus more on vision research,” said Hofland. “They began a robust advocacy campaign that included congressional testimony in favor of legislation to create a separate National Eye Institute.”

On August 16, 1968, capping a five-year RPB initiative, President Lyndon B. Johnson signed legislation creating the NEI.

Dr. Hofland discussed how, since that time, the NEI has been RPB’s most important “take-out” funder, meaning that RPB grants often enable researchers to collect the preliminary data they need to go on to get larger grants from NEI, which is the nation’s largest funder of vision research. “So, we see RPB and NEI as part of the same research funding pipeline,” said Hofland.

Hofland added: “RPB has been invested in the success of NEI from the very beginning, thanks to the vision of our founder. But what Jules Stein likely couldn’t have imagined is all that NEI would go on to accomplish in the years between its formation and its 50th anniversary. The record of success is just staggering. We at RPB are so proud of our continued relationship with the NEI and the many, many life-changing discoveries that have come out of this critical Institute.”

To learn more about 50 years of discovery at NEI, visit the Institute’s 50th anniversary website.

Related News: Events, Feature Story, Top Story

EMERGING VISION SCIENTISTS EDUCATE, THANK CONGRESS FOR RESEARCH APPROPRIATIONS

(NAEVR) held its Fourth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill and twenty early-stage investigators participated.

Read More

 

RESEARCH TO PREVENT BLINDNESS AND LIONS CLUBS INTERNATIONAL FOUNDATION TO CONTINUE LOW VISION RESEARCH AWARD PARTNERSHIP

Research to Prevent Blindness (RPB) and Lions Clubs International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.

Read More

 

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Read More

 

IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS

RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.

Read More

 

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2018 Recipient of RPB David F. Weeks Award for Outstanding AMD Research

RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.

Read More

 

Groundbreaking Gene Therapy for Retinal Disease

The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.